ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.

Zeyana Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.